MyFinsight
Home
Blog
About
Receipt of cash from
employee stock purchase...
$7,660
(774.43%↑ Y/Y)
Net cash provided by
(used in) financing...
$7,660
(-99.78%↓ Y/Y)
Net increase
(decrease) in cash and cash...
-$868,684
(-147.27%↓ Y/Y)
Canceled cashflow
$7,660
Inventory
-$665,707
(-1013.80%↓ Y/Y)
Accounts receivable
-$67,572
(-541.50%↓ Y/Y)
Amortization of intangible
assets
$55,888
(-63.88%↓ Y/Y)
Share and
warrant-based compensation...
$42,652
(-42.61%↓ Y/Y)
Accrued liabilities
$42,648
(139.55%↑ Y/Y)
Amortization of capitalized
contract costs
$38,185
(-58.39%↓ Y/Y)
Interest payable on note
$27,000
(-55.13%↓ Y/Y)
Allowance for credit
losses
$24,373
(109.75%↑ Y/Y)
Amortization of note payable
$20,833
(-82.64%↓ Y/Y)
Depreciation
$18,231
(-58.33%↓ Y/Y)
Operating leases
right-of-use assets
$12,304
(-1.91%↓ Y/Y)
Prepaid expenses and
other
-$5,957
(-124.42%↓ Y/Y)
Net cash used in
operating activities
-$845,749
(50.69%↑ Y/Y)
Effect of exchange rate
changes
-$30,595
(-146.63%↓ Y/Y)
Canceled cashflow
$1,021,350
Reserve for inventory
-$703,050
Net loss
-$576,852
(69.70%↑ Y/Y)
something is missing
-$250,000
Deferred revenue
-$211,605
(-34284.98%↓ Y/Y)
Accounts payable
-$98,227
(-237.72%↓ Y/Y)
Operating lease
liabilities
-$17,085
(-119.52%↓ Y/Y)
Capitalized contract costs
$10,280
(-79.22%↓ Y/Y)
Back
Back
Cash Flow
BIO KEY INTERNATIONAL INC (BKYI)
BIO KEY INTERNATIONAL INC (BKYI)
source: myfinsight.com